Effects of Prenatal Alcohol Exposure on Emotional and Cognitive Abilities in Adults
ALTEMO
Behavioral Exploration of Cognitive and Emotional Alterations in Adult Individuals Exposed to Alcohol During the Prenatal Period
2 other identifiers
interventional
144
1 country
2
Brief Summary
Hypothesis: Individuals presenting with prenatal alcohol exposure (PEA) show emotional abilities deficits, and imbalance between the two systems involved in decision-making according to dual-process models, namely an under-activated reflective system (involved in deliberate behaviors) and an over-activated affective-automatic one (involved in impulsive behaviors). Primary objective: To explore performance (as a percentage of correct answers) in an emotional facial expression decoding task in PEA participants compared to controls without alcohol disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2018
CompletedFirst Submitted
Initial submission to the registry
December 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2022
CompletedOctober 3, 2022
September 1, 2022
4 years
December 18, 2018
September 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of correct answers of an emotional facial expression (EFE)
Performance of an emotional facial expression (EFE) decoding task in EPA subjects and compare it to non-alcohol dependent controls
one day
Secondary Outcomes (5)
Psychopathological assessment by Mini International Neuropsychiatric Interview MINI
one day
Percentage of correct answers ant latency of behavioral answers
one day
State-Trait-Anxiety Inventory (STAI) score
one day
Beck Depression Inventory score
one day
Toronto Alexithymia Scale TAS-20 score
one day
Study Arms (4)
PEA patients without alcohol disorder
EXPERIMENTALA group of 36 PEA patient without alcohol-dependence (AD), performing 6 behavioral tasks.
PEA patients with alcohol disorder
SHAM COMPARATORA group of 36 PEA participants, currently alcohol-dependent, performing 6 behavioral tasks.
Healthy controls with AD father
SHAM COMPARATORA group of 36 non-alcohol-dependent controls whose father was alcohol-dependent during their childhood and adolescence, performing 6 behavioral tasks.
Healthy controls without AD father
SHAM COMPARATORA group of 36 non-alcohol-dependent controls whose father was not alcohol-dependent during their childhood and adolescence, performing 6 behavioral tasks.
Interventions
All tasks will be delivered using a laptop and E-Prime 2 software (Psychology Software Tools, Inc., Pittsburgh), which will also be used to collect behavioral responses.
Eligibility Criteria
You may qualify if:
- Man or woman aged between 18 and 60 years
- Able to understand and to speak French
- Able to understand Note of information and to sign consent form
- Available health insurance
- Normal (or corrected to normal) vision and audition
- For women: Negative pregnancy test or menopausal for at least one year
- For Group 1 only : PEA criteria and no alcohol consumption within the three days preceding the experiment.
- For Group 2 only : PEA criteria, diagnosed with severe alcohol addiction and currently abstinent (for at least 15 days).
- For Group 3 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment and father diagnosed with severe alcohol addiction.
- For Group 4 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment.
You may not qualify if:
- Refusal of participation after clear and fair information on the study.
- Visual or auditory sensory disability to participate in the study.
- Benzodiazepines and / or Antipsychotic concomitant treatment.
- History of (or current) neurologic disease
- History of (or current) psychiatric disorder (apart alcohol-dependence for the PEA-alcohol-dependent group)
- Psychoactive Substance Use or Abuse other than tobacco and alcohol.
- Pregnant or breast-feeding women.
- Underage (\<18 yo) or adults under guardianship, judicial protection, or deprived of liberty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CSAPA
Lille, 59037, France
CHRU Lille, Fontan2
Lille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier COTTENCIN, MD, PhD
University Hospital, Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2018
First Posted
January 4, 2019
Study Start
November 8, 2018
Primary Completion
November 11, 2022
Study Completion
November 11, 2022
Last Updated
October 3, 2022
Record last verified: 2022-09